Cook, S, et al. Year-by-year lymphopenia rates in patients with relapsing multiple sclerosis (RMS) treated with cladribine tablets 3.5mg/kg in CLARITY and re-treated in CLARITY Extension. EAN 2017, EP1147.
Glatirameeracetaat: ook risico op anafylactische reacties lang na start behandeling
sep 2024 | Multipele Sclerose